253 related articles for article (PubMed ID: 32540813)
1. [Mutltifaceted biological roles of adiponectin].
Cuerq C; Morineau G; Dufour-Rainfray D; Vatier C; Fellahi S; Vigouroux C; Genoux A; Lacorte JM; Charchour R; Fève B; Capeau J; Collet C; Bastard JP;
Ann Biol Clin (Paris); 2020 Jun; 78(3):243-252. PubMed ID: 32540813
[TBL] [Abstract][Full Text] [Related]
2. Adiponectin and adiponectin receptors in obesity-linked insulin resistance.
Kadowaki T; Yamauchi T; Kubota N; Hara K; Ueki K
Novartis Found Symp; 2007; 286():164-76; discussion 176-82, 200-3. PubMed ID: 18269182
[TBL] [Abstract][Full Text] [Related]
3. Adiponectin, structure, function and pathophysiological implications in non-alcoholic fatty liver disease.
Méndez-Sánchez N; Chavez-Tapia NC; Zamora-Valdés D; Uribe M
Mini Rev Med Chem; 2006 Jun; 6(6):651-6. PubMed ID: 16787375
[TBL] [Abstract][Full Text] [Related]
4. Latent Inflammation and Defect in Adipocyte Renewal as a Mechanism of Obesity-Associated Insulin Resistance.
Vorotnikov AV; Stafeev IS; Menshikov MY; Shestakova MV; Parfyonova YV
Biochemistry (Mosc); 2019 Nov; 84(11):1329-1345. PubMed ID: 31760921
[TBL] [Abstract][Full Text] [Related]
5. Protective roles of adiponectin in obesity-related fatty liver diseases: mechanisms and therapeutic implications.
Wang Y; Zhou M; Lam KS; Xu A
Arq Bras Endocrinol Metabol; 2009 Mar; 53(2):201-12. PubMed ID: 19466213
[TBL] [Abstract][Full Text] [Related]
6. Adiponectin: protection of the endothelium.
Lam KS; Xu A
Curr Diab Rep; 2005 Aug; 5(4):254-9. PubMed ID: 16033674
[TBL] [Abstract][Full Text] [Related]
7. Fatty liver as a consequence and cause of insulin resistance: lessons from type 2 diabetic liver.
Takamura T; Misu H; Ota T; Kaneko S
Endocr J; 2012; 59(9):745-63. PubMed ID: 22893453
[TBL] [Abstract][Full Text] [Related]
8. Signaling mechanisms underlying the insulin-sensitizing effects of adiponectin.
Cheng KK; Lam KS; Wang B; Xu A
Best Pract Res Clin Endocrinol Metab; 2014 Jan; 28(1):3-13. PubMed ID: 24417941
[TBL] [Abstract][Full Text] [Related]
9. The role of leptin/adiponectin ratio in metabolic syndrome and diabetes.
López-Jaramillo P; Gómez-Arbeláez D; López-López J; López-López C; Martínez-Ortega J; Gómez-Rodríguez A; Triana-Cubillos S
Horm Mol Biol Clin Investig; 2014 Apr; 18(1):37-45. PubMed ID: 25389999
[TBL] [Abstract][Full Text] [Related]
10. [Role of the endocrine system in the pathogenesis of non-alcoholic fatty liver disease].
Hagymási K; Reismann P; Rácz K; Tulassay Z
Orv Hetil; 2009 Nov; 150(48):2173-81. PubMed ID: 19923096
[TBL] [Abstract][Full Text] [Related]
11. Inflammatory mechanisms linking obesity and metabolic disease.
Saltiel AR; Olefsky JM
J Clin Invest; 2017 Jan; 127(1):1-4. PubMed ID: 28045402
[TBL] [Abstract][Full Text] [Related]
12. Modulation of adiponectin as a potential therapeutic strategy.
Lim S; Quon MJ; Koh KK
Atherosclerosis; 2014 Apr; 233(2):721-728. PubMed ID: 24603219
[TBL] [Abstract][Full Text] [Related]
13. Obesity modulation - the role in carcinogenesis.
Legakis I; Syrigos K
Anticancer Agents Med Chem; 2010 Jul; 10(6):481-90. PubMed ID: 20698826
[TBL] [Abstract][Full Text] [Related]
14. Pathway-selective insulin resistance and metabolic disease: the importance of nutrient flux.
Otero YF; Stafford JM; McGuinness OP
J Biol Chem; 2014 Jul; 289(30):20462-9. PubMed ID: 24907277
[TBL] [Abstract][Full Text] [Related]
15. Metabolism and insulin signaling in common metabolic disorders and inherited insulin resistance.
Højlund K
Dan Med J; 2014 Jul; 61(7):B4890. PubMed ID: 25123125
[TBL] [Abstract][Full Text] [Related]
16. Relationships between adiponectin levels, the metabolic syndrome, and type 2 diabetes: a literature review.
Frankenberg ADV; Reis AF; Gerchman F
Arch Endocrinol Metab; 2017 Dec; 61(6):614-622. PubMed ID: 29412387
[TBL] [Abstract][Full Text] [Related]
17. Pathogenesis of the metabolic syndrome: insights from monogenic disorders.
Murphy R; Carroll RW; Krebs JD
Mediators Inflamm; 2013; 2013():920214. PubMed ID: 23766565
[TBL] [Abstract][Full Text] [Related]
18. The role of adiponectin in obesity, diabetes, and cardiovascular disease.
Kawano J; Arora R
J Cardiometab Syndr; 2009; 4(1):44-9. PubMed ID: 19245516
[TBL] [Abstract][Full Text] [Related]
19. Physiological and pathophysiological roles of adiponectin and adiponectin receptors in the integrated regulation of metabolic and cardiovascular diseases.
Yamauchi T; Kadowaki T
Int J Obes (Lond); 2008 Dec; 32 Suppl 7():S13-8. PubMed ID: 19136982
[TBL] [Abstract][Full Text] [Related]
20. Roles of adipose restriction and metabolic factors in progression of steatosis to steatohepatitis in obese, diabetic mice.
Larter CZ; Yeh MM; Van Rooyen DM; Teoh NC; Brooling J; Hou JY; Williams J; Clyne M; Nolan CJ; Farrell GC
J Gastroenterol Hepatol; 2009 Oct; 24(10):1658-68. PubMed ID: 19788606
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
